DALLAS, June 14, 2012 /PRNewswire/ -- Securities lawyers at Goldfarb LLP announce an investigation into alleged violations of shareholder protection laws by officers and directors of IntegraMed America, Inc. (NASDAQ: INMD) in connection with a buyout for $14.05 per share Sagard Capital Partners. Concerned INMD investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or email@example.com about their rights and remedies. "The proposed buyout price appears unfair because at least one analyst has targeted INMD's value at $17.00 per share," said Hamilton Lindley. "We will ascertain whether the company has been adequately and fairly shopped and that all relevant information is disclosed so that shareholder interests are protected in terms of price and information." Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. INMD stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-583-2855 with questions or concerns. Hamilton Lindley Goldfarb LLP2501 N. Harwood, Ste. 1801 Dallas, TX 75201(877) 583-2855 Toll Free Telephone (214) 583-2233 Local Phone Number (214) 583-2234 Fax Number www.goldfarbllp.com SOURCE Goldfarb LLP
Shares of IntegraMed America (Nasdaq:INMD) have taken a tremendous swing upward. The stock is trading at $13.71 as of 9:55 a.m. ET, 20.9% above Friday's closing price of $11.34. Volume is at 476,658, 22.5 times the daily average of 21,200.